X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs GSK PHARMA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA GSK PHARMA ABBOTT INDIA/
GSK PHARMA
 
P/E (TTM) x 35.1 55.8 63.0% View Chart
P/BV x 9.1 11.1 82.0% View Chart
Dividend Yield % 0.8 2.6 29.2%  

Financials

 ABBOTT INDIA   GSK PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
GSK PHARMA
Mar-18
ABBOTT INDIA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs6,1102,760 221.4%   
Low Rs3,9962,040 195.9%   
Sales per share (Unadj.) Rs1,552.2339.0 457.9%  
Earnings per share (Unadj.) Rs188.841.4 455.9%  
Cash flow per share (Unadj.) Rs196.445.9 427.9%  
Dividends per share (Unadj.) Rs55.0035.00 157.1%  
Dividend yield (eoy) %1.11.5 74.6%  
Book value per share (Unadj.) Rs796.6242.9 328.0%  
Shares outstanding (eoy) m21.2584.70 25.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.37.1 46.0%   
Avg P/E ratio x26.857.9 46.2%  
P/CF ratio (eoy) x25.752.3 49.2%  
Price / Book Value ratio x6.39.9 64.2%  
Dividend payout %29.184.5 34.5%   
Avg Mkt Cap Rs m107,376203,280 52.8%   
No. of employees `0003.3NA-   
Total wages/salary Rs m3,9375,234 75.2%   
Avg. sales/employee Rs Th9,929.3NM-  
Avg. wages/employee Rs Th1,185.1NM-  
Avg. net profit/employee Rs Th1,207.7NM-  
INCOME DATA
Net Sales Rs m32,98528,715 114.9%  
Other income Rs m1,170545 214.5%   
Total revenues Rs m34,15529,260 116.7%   
Gross profit Rs m5,2455,059 103.7%  
Depreciation Rs m162380 42.6%   
Interest Rs m382 1,910.0%   
Profit before tax Rs m6,2155,222 119.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0178 0.0%   
Tax Rs m2,2031,892 116.4%   
Profit after tax Rs m4,0123,508 114.4%  
Gross profit margin %15.917.6 90.3%  
Effective tax rate %35.436.2 97.8%   
Net profit margin %12.212.2 99.6%  
BALANCE SHEET DATA
Current assets Rs m22,65521,815 103.9%   
Current liabilities Rs m6,68115,999 41.8%   
Net working cap to sales %48.420.3 239.1%  
Current ratio x3.41.4 248.7%  
Inventory Days Days6564 101.9%  
Debtors Days Days2919 156.0%  
Net fixed assets Rs m83512,475 6.7%   
Share capital Rs m213847 25.1%   
"Free" reserves Rs m16,71519,726 84.7%   
Net worth Rs m16,92820,573 82.3%   
Long term debt Rs m06 0.0%   
Total assets Rs m24,16239,475 61.2%  
Interest coverage x163.72,612.0 6.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.40.7 187.7%   
Return on assets %16.88.9 188.5%  
Return on equity %23.717.1 139.0%  
Return on capital %36.926.2 140.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m369564 65.3%   
Fx outflow Rs m3,8077,429 51.2%   
Net fx Rs m-3,438-6,865 50.1%   
CASH FLOW
From Operations Rs m1,5274,728 32.3%  
From Investments Rs m-2,148-1,042 206.2%  
From Financial Activity Rs m-1,024-3,066 33.4%  
Net Cashflow Rs m-1,646620 -265.5%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 50.7 147.9%  
Indian inst/Mut Fund % 7.9 10.2 77.5%  
FIIs % 0.1 23.8 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 15.4 111.0%  
Shareholders   18,270 102,036 17.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  FULFORD INDIA  

Compare ABBOTT INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

GSK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 26.0% (Quarterly Result Update)

Feb 5, 2019 | Updated on Feb 5, 2019

For the quarter ended December 2018, GSK PHARMA has posted a net profit of Rs 1 bn (up 26.0% YoY). Sales on the other hand came in at Rs 8 bn (up 17.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 22.7% YoY). Sales on the other hand came in at Rs 8 bn (down 2.4% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Feb 22, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - FDC LTD. COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS